These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8039279)

  • 1. Ultraviolet-A1 irradiation decreases clinical disease activity and autoantibodies in patients with systemic lupus erythematosus.
    McGrath H
    Clin Exp Rheumatol; 1994; 12(2):129-35. PubMed ID: 8039279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultraviolet-A1 (340-400 nm) irradiation therapy in systemic lupus erythematosus.
    McGrath H; Martínez-Osuna P; Lee FA
    Lupus; 1996 Aug; 5(4):269-74. PubMed ID: 8869897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-SSA and anti-SSB autoantibodies in Sjögren's syndrome and lupus erythematous in Mexican Mestizos.
    Cortes JJ; Sabanes J; Reies PA
    Clin Exp Rheumatol; 1985; 3(3):277-8. PubMed ID: 3876903
    [No Abstract]   [Full Text] [Related]  

  • 4. Failure to detect antibodies to the second extracellular loop of the serotonin 5-HT4 receptor in systemic lupus erythematosus and primary Sjögren's syndrome.
    Cavill D; Waterman S; Gordon TP
    Lupus; 2002; 11(3):197-8. PubMed ID: 11999887
    [No Abstract]   [Full Text] [Related]  

  • 5. Symptomatic secondary Sjögren's syndrome in patients with systemic lupus erythematosus (SLE). Relation to anti-SS-A and anti-SS-B autoantibodies.
    Jonsson H; Nived O; Sturfelt G; Norberg R
    Scand J Rheumatol Suppl; 1986; 61():166-9. PubMed ID: 3495873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resolution of the identity of certain antigen-antibody systems in systemic lupus erythematosus and Sjögren's syndrome: an interlaboratory collaboration.
    Alspaugh M; Maddison P
    Arthritis Rheum; 1979 Jul; 22(7):796-8. PubMed ID: 110340
    [No Abstract]   [Full Text] [Related]  

  • 7. Autoantibodies to alpha-fodrin in primary Sjögren's syndrome and SLE detected by an in vitro transcription and translation assay.
    Nordmark G; Rorsman F; Rönnblom L; Cajander S; Taussig MJ; Kämpe O; Winqvist O
    Clin Exp Rheumatol; 2003; 21(1):49-56. PubMed ID: 12673889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opsonization of late apoptotic cells by systemic lupus erythematosus autoantibodies inhibits their uptake via an Fcgamma receptor-dependent mechanism.
    Reefman E; Horst G; Nijk MT; Limburg PC; Kallenberg CG; Bijl M
    Arthritis Rheum; 2007 Oct; 56(10):3399-411. PubMed ID: 17907194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Psychiatric manifestations of lupus erythematosus systemic and Sjogren's syndrome].
    Ampélas JF; Wattiaux MJ; Van Amerongen AP
    Encephale; 2001; 27(6):588-99. PubMed ID: 11865567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-Ro (SSA) and anti-La (SSB) antibodies in lupus erythematosus and in Sjögren's syndrome.
    Lee LA
    Arch Dermatol; 1988 Jan; 124(1):61-2. PubMed ID: 3257370
    [No Abstract]   [Full Text] [Related]  

  • 11. Longterm ultraviolet-A1 irradiation therapy in systemic lupus erythematosus.
    Molina JF; McGrath H
    J Rheumatol; 1997 Jun; 24(6):1072-4. PubMed ID: 9195511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti Ro/La antibodies and their clinical association.
    Ben-Chetrit E
    Isr J Med Sci; 1997 Apr; 33(4):251-3. PubMed ID: 9347873
    [No Abstract]   [Full Text] [Related]  

  • 13. Antinuclear autoantibodies: discordance among four different assays.
    Pacheco Y; Monsalve DM; Acosta-Ampudia Y; Rojas C; Anaya JM; Ramírez-Santana C
    Ann Rheum Dis; 2020 Jan; 79(1):e6. PubMed ID: 30459278
    [No Abstract]   [Full Text] [Related]  

  • 14. [Differentiation with immunofluorescence of complement fixing and non-fixing antinuclear factors in patients with and without disseminated lupus erythematosus].
    Peltier AP
    Pathol Biol; 1968 Apr; 16(7):439-44. PubMed ID: 4882383
    [No Abstract]   [Full Text] [Related]  

  • 15. Autoantibodies in lupus and its variants: experience in 1000 patients.
    Hughes GR
    Br Med J (Clin Res Ed); 1984 Aug; 289(6441):339-42. PubMed ID: 6432088
    [No Abstract]   [Full Text] [Related]  

  • 16. [Evaluation of usefulness of Polycheck method in the detection autoantibodies in patients with systemic lupus erythematosus, Sjögren's syndrome and systemic sclerosis].
    Dryglewskal M; Majdan M; Koszarny A; Grytal A; Grzywnowicz M
    Wiad Lek; 2015; 68(3):252-8. PubMed ID: 26753209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical, serologic, and genetic profiles of patients with associated Sjögren's syndrome and systemic lupus erythematosus.
    Szanto A; Szodoray P; Kiss E; Kapitany A; Szegedi G; Zeher M
    Hum Immunol; 2006 Nov; 67(11):924-30. PubMed ID: 17145372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between anti-Ro (SS-A) antibody-positive Sjögren's syndrome and anti-Ro (SS-A) antibody-positive lupus erythematosus.
    Provost TT; Talal N; Harley JB; Reichlin M; Alexander E
    Arch Dermatol; 1988 Jan; 124(1):63-71. PubMed ID: 3257371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Autoantibodies in patients with Sjögren's syndrome and their clinical significance].
    Miyawaki S
    Nihon Rinsho; 1995 Oct; 53(10):2422-8. PubMed ID: 8531349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of antinuclear antibody and other immunohematological profiles among primary Sjögren's syndrome, secondary Sjögren's syndrome associated with rheumatoid arthritis or systemic lupus erythematosus, and corresponding systemic disease.
    Ichikawa Y; Takaya M; Shimizu H; Uchiyama M; Moriuchi J; Morita K; Hoshina Y; Horiki T
    Tokai J Exp Clin Med; 1993 Dec; 18(3-6):133-8. PubMed ID: 7701526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.